HK$ 4.98
Key Takeaways
Risk factor
Strong & resilient to price shocks
Profitability factor
Greatly undervalued vs peers
About
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Target Price
The average target price of 3320.HK is 6.4 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
